Authors
Latest:
Why Pharmacists Should Recommend Asthma SpacersPharmacists should recommend asthma spacers to patients taking inhaler therapy for uncontrolled asthma because the devices can help improve hand-breath coordination while reducing side effects of inhaled medication.
Latest:
Together Beyond COVID-19: A Look at the Future of the Pharmaceutical IndustryIn a short time, COVID-19 has increased our dependency on technology and pharmaceutical companies are actively investigating this digital transformation.
Latest:
Bevacizumab Intravitreal Injection Intraocular Pressure Found Safe, TolerableIncrease in intraocular pressure found to be tolerable to the corneal endothelium and safe for treating central serous chorioretinopathy or diabetic macular edema.
Latest:
Smoking Cessation: Overcoming Nicotine DependencePharmacists can learn about the available interventions for smoking cessation.
Latest:
Modeled Cost Differences Associated With Use of Levonorgestrel Intrauterine DevicesThis analytic model assessed the per-woman cost differences between the use of 2 levonorgestrel-releasing intrauterine devices, from a US payer perspective.
Latest:
Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related TherapiesExamination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.
Latest:
Biosimilars: Where Are They Now?Although biosimilars may be years away from their US debut, now is the time for pharmacists to educate themselves on this new class of agents so that they will be prepared to provide support for their appropriate use.
Latest:
Telepharmacy and Its Impact on Formulary AdherenceTelepharmacy is comparable to usual care in transitioning members new to an HMO onto formulary medications.
Latest:
Seize the Moment Now to Discuss VaccinesVaccines are extremely topical, with questions routinely being asked, particularly during the winter season.
Latest:
Study Finds Icosapent Ethyl May Be Beneficial for Treating Cardiovascular DiseaseBecause high triglycerides have been associated with an increased risk for CVD, lowering this lab value should also reduce circulatory system risks.
Latest:
Hybrid Models Can Transform Team ChemistryMorristown Medical Center’s area-based pharmacist program leads to an increase in direct patient contact and opportunities for interventions.
Latest:
Growth of Health System-Based Specialty Pharmacy to Continue in 2020, Reducing Cost of CareAlthough the prevalence of health system-based specialty pharmacies has grown steadily over the past decade, 2020 will mark a critical year.
Latest:
Pharmacists on the Multidisciplinary Team: Implementing Best Practices in Chemo-Induced Nausea and Vomiting (CINV) ManagementThis Continuing Education activity is supported by educational grants from Eisai Inc., Merck Sharp & Dohme Corp., and Tesaro, Inc.
Latest:
An Intermittent Reinforcement Platform to Increase Adherence to MedicationsAn automated reinforcement platform was shown to increase statin adherence by 34.6%.
Latest:
There Is an App for ThatIn spring 2018, the FDA approved the Dexcom G6 CGM System, an integrated continuous glucose monitoring (CGM) system for those with type 1 or type 2 diabetes who are as young as 2 years.
Latest:
House Bill Takes Aim at Direct-to-Consumer AdvertisingDirect-to-consumer advertising is a continuously growing sector of the pharmaceutical industry’s cost expenditure.
Latest:
Helping Patients Manage Cardiovascular DiseaseAdherence to medications can aid in preventing and treating CVD.
Latest:
Pharmacies Need to Solve Workforce ShortagesA shortage of pharmacy technicians affects both hospitals and retail pharmacies and requires employers to focus on building a pipeline of job candidates who possess the skills they need.
Latest:
Highly Contagious UK COVID-19 Variant May Become Dominant Strain by MarchB.1.1.7, or otherwise known as VOC 202012/01, may lead to a large increase in the number of COVID-19 cases in the United States and may become the dominant strain of the virus in the coming months.
Latest:
Large-Scale, Community-Based Trial of a Personalized Drug-Related Problem Rectification SystemA controlled trial of a system for rectifying and preventing drug-related problems was conducted to evaluate improvement in the efficiency of resource utilization.
Latest:
Impact of Medicare Part D on Utilization and ExpendituresExamination of pharmacy behaviors before and after implementation indicated that restrictions in pharmacy benefits may not deter utilization for Part D.
Latest:
Case Studies (January 2020)What could be causing this patient's involuntary, repetitive movements in her arms and legs?
Latest:
Telemedicine Can Help Facilitate Treatment for Opioid Use DisorderProgram provides a virtual assessment and treatment with buprenorphine, a medication for opioid cravings and withdrawal symptoms.
Latest:
Compliance and Cost of Biologic Therapies for Rheumatoid ArthritisMedication compliance is associated with lower overall and disease-related healthcare costs in patients with moderate to severe rheumatoid arthritis receiving biologic therapies.
Latest:
Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia SyndromeWhile fibromyalgia is associated with a small increase in healthcare costs compared with matched controls, chronic opioid use in these patients results in a large increase.
Latest:
Drug Coverage and Decision Making in Medicare Part D EnrolleesThis pharmacy adjudication, prescription fulfillment study demonstrates how a sudden drop of prescription drug coverage has an effect on Medicare Part D patients' prescription decisions.
Latest:
Bringing Out the Best with Less: The Health-System and Integrated Delivery NetworkDepartments of pharmacy in the hospital will be called upon to work within existing budgets while providing additional services such as medication reconciliation and patient education.
Latest:
Trends Associated with Implementing and Lifting a Pregabalin Step Therapy PolicyThis study examined the impact of a pregabalin step therapy policy on utilization and medical costs in Humana’s Medicare and commercial plans.
